Laboratories, Inc. Recalls Trihexyphenidyl Hydrochloride Tablets
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
July 20, 1999
Rockford, IL (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that UDL Laboratories, Inc. is recalling
Trihexyphenidyl Hydrochloride Tablets because of mislabeling. Some blister strips
are held in shelf unit cartons (100's) labeled as Allopurinol Tablets, 300 mg. The blister
strips are correctly labeled.
Trihexyphenidyl Hydrochloride Tablets, 5 mg, in 100
tablet blister strips of 10 tablets, Rx oral antispasmodic tablet used as an adjunct in
the treatment of all forms of parkinsonism. NDC 51079-124-20.
Lederle Pharmaceutical, Division of American Cyanamid, Pearl River, New York.
UDL Laboratories, Inc., Rockford, Illinois (repacker), by letter dated June 14,
1999. Firm-initiated recall ongoing.
3,624 unit cartons were distributed; firm estimated that 25 percent of the product
remained on market at time of recall initiation.